| HCF1 and OCT2 cooperate with EBNA1 to enhance OriP-dependent transcription and episome maintenance of latent Epstein-Barr virus J Dheekollu, A Wiedmer, D Sentana-Lledo, J Cassel, T Messick, ... Journal of Virology 90 (11), 5353-5367, 2016 | 17 | 2016 |
| Seasons, searches, and intentions: what the internet can tell us about the bed bug (Hemiptera: Cimicidae) epidemic D Sentana-Lledo, CM Barbu, MN Ngo, Y Wu, K Sethuraman, MZ Levy Journal of Medical Entomology 53 (1), 116-121, 2016 | 17 | 2016 |
| EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates D Sentana-Lledo, E Academia, H Viray, D Rangachari, SS Kobayashi, ... Translational Lung Cancer Research 12 (7), 1590, 2023 | 16 | 2023 |
| Optimal assessment of quality of life for patients with prostate cancer LG Briggs, D Sentana-Lledo, DE Lage, QD Trinh, AK Morgans Therapeutic Advances in Medical Oncology 14, 17588359221141306, 2022 | 6 | 2022 |
| Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer D Sentana-Lledo, H Viray, AJ Piper-Vallillo, P Widick, D Rangachari, ... Lung Cancer 172, 124-126, 2022 | 6 | 2022 |
| Immune mechanisms behind prostate cancer in men of African ancestry: A review D Sentana‐Lledo, O Sartor, SP Balk, DJ Einstein The Prostate 82 (8), 883-893, 2022 | 5 | 2022 |
| EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window … W Shaffer, IS Kobayashi, D Sentana-Lledo, S Sundararaman, MD Lee, ... Lung Cancer 181, 107250, 2023 | 2 | 2023 |
| Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED) D Sentana-Lledo, X Chu, DF Jarrard, MA Carducci, RS DiPaola, ... European Urology Oncology, 2024 | 1 | 2024 |
| Prevalence and Morbidity of Local Treatment-Related Side Effects in Metastatic Prostate Cancer Patients D Sentana-Lledo, LE Dodge, P Chang, DJ Einstein Urologic Oncology: Seminars and Original Investigations 41 (4), 204. e1-204. e6, 2023 | 1 | 2023 |
| Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer D Sentana-Lledo, AK Morgans Current Oncology Reports 26 (3), 299-306, 2024 | | 2024 |
| Days spent with healthcare contact by patients with metastatic castrate-resistant prostate cancer in the last year of life. D Sentana Lledo, A Barnett, DJ Einstein, A Gupta, AK Morgans Journal of Clinical Oncology 42 (4_suppl), 100-100, 2024 | | 2024 |
| Evaluating efficiency of electronic consult requests in an outpatient classical hematology clinic. A Santopietro, RH Bekendam, A Dibibar, B Lam, M Mahony, ... JCO Oncology Practice 19 (11_suppl), 46-46, 2023 | | 2023 |
| Patient reported quality of life (QOL) and survival outcomes: Analysis of ECOG-ACRIN E3805 chemohormonal androgen ablation randomized trial (CHAARTED) in prostate cancer (PCa). D Sentana Lledo, X Chu, DF Jarrard, MA Carducci, RS DiPaola, ... Journal of Clinical Oncology 41 (16_suppl), 5014-5014, 2023 | | 2023 |
